Business Description
Orthofix Medical Inc
NAICS : 339112
SIC : 3841
ISIN : US68752M1080
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.19 | |||||
Equity-to-Asset | 0.62 | |||||
Debt-to-Equity | 0.25 | |||||
Debt-to-EBITDA | -3.49 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 1.5 | |||||
Beneish M-Score | -2.88 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -1 | |||||
3-Year Book Growth Rate | -4.3 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 6.47 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 18.22 | |||||
9-Day RSI | 30.21 | |||||
14-Day RSI | 37.6 | |||||
6-1 Month Momentum % | 22.58 | |||||
12-1 Month Momentum % | 31.03 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.48 | |||||
Quick Ratio | 1.13 | |||||
Cash Ratio | 0.17 | |||||
Days Inventory | 315.76 | |||||
Days Sales Outstanding | 57.28 | |||||
Days Payable | 77.96 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -24.1 | |||||
Shareholder Yield % | -12.64 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 67.18 | |||||
Operating Margin % | -9.97 | |||||
Net Margin % | -15.62 | |||||
FCF Margin % | -9.54 | |||||
ROE % | -20.28 | |||||
ROA % | -13.33 | |||||
ROIC % | -9.85 | |||||
3-Year ROIIC % | -45.57 | |||||
ROC (Joel Greenblatt) % | -27.55 | |||||
ROCE % | -13.64 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.75 | |||||
PB Ratio | 1.07 | |||||
Price-to-Tangible-Book | 2.4 | |||||
EV-to-EBIT | -6.79 | |||||
EV-to-EBITDA | -17.73 | |||||
EV-to-Forward-EBITDA | 10.17 | |||||
EV-to-Revenue | 0.9 | |||||
EV-to-Forward-Revenue | 0.82 | |||||
EV-to-FCF | -9.43 | |||||
Price-to-Projected-FCF | 1.71 | |||||
Price-to-Median-PS-Value | 0.44 | |||||
Price-to-Net-Current-Asset-Value | 11.64 | |||||
Earnings Yield (Greenblatt) % | -14.73 | |||||
FCF Yield % | -12.61 | |||||
Forward Rate of Return (Yacktman) % | 21.59 |